RNS Number : 7935D
BlueRock Diamonds PLC
26 June 2023
 

BlueRock Diamonds PLC / AIM: BRD / Sector: Natural Resources

26 June 2023

BlueRock Diamonds PLC - In Administration ('BlueRock', 'BRD' or the 'Company')

Accounts Update

 

BlueRock announces that the Company will not be in a position to publish its annual report and accounts for the year ended 31 December 2022 by 30 June 2023, being the deadline provided by Rule 19 of the AIM Rules for Companies ("AIM Rules").

Trading in the Company's shares on AIM was suspended on 24 February 2023 and in accordance with Rule 41 of the AIM Rules, the admission of the Company's shares to trading on AIM will be cancelled where these have been suspended from trading for six months.

Trading in the Company's shares on AIM will remain suspended and further announcements will be made in due course as appropriate.

As previously announced, the Company was placed into Administration on 5 June 2023, and Allister Manson and Trevor Binyon of Opus Restructuring LLP were appointed the Joint Administrators.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

**ENDS**

 

 

For further information, please visit BlueRock's website www.bluerockdiamonds.co.uk or contact:

 

BlueRock Diamonds PLC (in Administration)

Allister Manson & Trevor Binyon (Joint Administrators)

bradley.parrott@opusllp.com

ben.ekbery@opusllp.com

Tel: +44 (0)20 3326 6454

SP Angel (NOMAD and Broker)

Stuart Gledhill / Harry Davies-Ball

 

Tel: +44 (0)20 3470 0470

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEXLFLXQLEBBE